• Product NameEpirubicin hydrochloride
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityEpirubicin hydrochloride, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.
• Target NameTopoisomerase inhibitor
• CAS No. 56390-09-1
• Calculated MW 579.98
• Formulation C27H30ClNO11
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
  Pathways:DNA Damage/DNA Repair
  Receptor:Topo
  Boling pt:810.3C
  Melting pt:185C
  Solubility:Water: 100 mg/mL warmed (172.41 mM); DMSO: 100 mg/mL (172.41 mM)
  Appearance:Red Crystal Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Grataroli R, et al. Biochem Pharmacol. 1993 Aug 3;46(3):349-55.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting